Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04313504
Title Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Trisha Wise-Draper
Indications

head and neck squamous cell carcinoma

Therapies

Dostarlimab-gxly + Niraparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Cincinnati Medical Center Recruiting Cincinnati Ohio 45219 United States Details
Ohio State University Not yet recruiting Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field